Redox Signaling as a Therapeutic Target to Inhibit Myofibroblast Activation in Degenerative Fibrotic Disease

First Page		Document Content
Signal transduction Wound healing CD90 Fibroblast Dermal fibroblast Angiogenesis Cardiac fibrosis Phosphodiesterase Platelet-derived growth factor Biology Molecular biology Myofibroblast		Redox Signaling as a Therapeutic Target to Inhibit Myofibroblast Activation in Degenerative Fibrotic Disease Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 791,95 KB Share Document on Facebook

	Genes & Cancer, Advance Publicationwww.impactjournals.com/Genes&Cancer FGF19 functions as autocrine growth factor for hepatoblastoma David J. Elzi1, Meihua Song1, Barron Blackman1, Susan T. Weintraub2, Dolores DocID: 1rtzW - View Document
	NIH Public Access Author Manuscript Bone. Author manuscript; available in PMC 2013 May 1. NIH-PA Author Manuscript DocID: 1qrVS - View Document
	Discovering drugs by using mixed cell cultures MarkAnthony Bray, David Logan and Anne Carpenter Background The problem DocID: 1qrVR - View Document
	Why we focus on Cell Signalling Cell signalling is the process by which our cells communicate with each other and with their environment. Pathways that govern how cells proliferate, move, survive and differentiate repres DocID: 1qkw6 - View Document
	EUROPEAN PATENT OFFICE U.S. PATENT AND TRADEMARK OFFICE CPC NOTICE OF CHANGES 234 DATE: AUGUST 1, 2016 PROJECT DP0077 DocID: 1qaiO - View Document